患有慢性阻塞性肺病的人的甲状腺激素:系统性审查和元分析
Pilar Fandos Vázquez1, Jesús Díez-Manglano2
1Department of Medicine, Dermatology and Psychiatry, University of Zaragoza, Spain.
Respiratory medicine
|April 16, 2025
概括
甲状腺激素水平,包括甲状腺刺激激素 (TSH) 和总T3,在患有慢性阻塞性肺病 (COPD) 的患者中降低,特别是在急性恶化和严重阶段.
科学领域:
- 内分泌学 在内分泌学.
- 肺部病理学 肺部病理学
- 代谢医学是一种代谢医学.
背景情况:
- 慢性阻塞性肺病 (COPD) 是一种复杂的呼吸系统疾病,具有全身影响.
- 甲状腺功能障碍可以影响各种生理过程,其与COPD的关系需要进一步阐明.
研究的目的:
- 通过全面的元分析,系统地评估COPD对甲状腺激素水平的影响.
主要方法:
- 通过使用来自多个数据库 (PubMed,Embase,Web of Science等) 的数据进行了元分析. 在2023年12月31日之前.
- 使用随机效应模型的逆方差方法来计算聚合平均差异 (MD) 和95%置信区间 (CI).
- 使用I2统计学来评估异质性,并进行元回归来探索变异来源.
主要成果:
- 分析包括25项研究,包括1613名COPD患者和1792名对照.
- 与对照组相比,COPD患者的TSH和总T3水平明显降低.
- 经历COPD急性恶化患者的TSH,自由T3和总T3水平降低. 与COPD严重程度相关的TSH和总T3水平.
结论:
- 慢性肺炎与TSH和总T3水平的降低有关.
- 这些甲状腺激素变化在严重的COPD和急性恶化期间更为明显,这表明呼吸系统疾病严重程度和甲状腺功能之间存在联系.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
COPD: Management Using Bronchodilators and Corticosteroids
144
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
144
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
Synthesis and Regulation of Thyroid Hormones
4.0K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
4.0K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K


